Investor Presentation Q1-Q3 2020

76 Investor presentation First nine months of 2020 Growth momentum has increased driven by demographics and the Market Fit approach International Operations is diverse and covers 190 markets 14% 430M live with diabetes 12% 10% 570M live with obesity 8% 6% 4% IO's share of revenue 9M 2020 2% NAO 47% ΙΟ 53% NAO: North America Operations; IO: International Operations; SOG: Share of Growth Novo NordiskⓇ Historic growth has been in the range of 4-6% Growth momentum has benefitted from the Market Fit approach 12% 40% 30% mall 20% 10% 0% 2013 9M Aug Market Fit 2020 approach 2017 Growth rate range introduced NN Diabetes market share NN Diabetes SOG -Market growth NN Diabetes growth 30% 23% 13% 9% Aug 2020

View entire presentation